Gastrointestinal Oncology: Evidence and AnalysisPeter McCulloch CRC Press, 19 kwi 2016 - 400 This reference discusses best practices for the management of patients with cancers of the esophagus, stomach, colon, liver, and pancreas. Focusing on a wide variety of GI carcinomas by organ and tumor type, this source provides expert coverage of diagnostic, staging, and treatment procedures by seasoned oncologists and radiologists, and offers in- |
Spis treści
Chapter 1 Surgical and Ablative Treatment of Barretts Esophagus and Its Complications | 1 |
Chapter 2 The Role of Drugs and Nutrition in the Prevention of Esophageal Adenocarcinoma Associated with Barretts Esophagus | 17 |
Chapter 3 Surgical Treatment of Esophageal Carcinoma | 33 |
Chapter 4 Surgical Treatment of Carcinomas Involving the Esophagogastric Junction | 43 |
Chapter 5 The Role of Chemotherapy and Radiotherapy in the Management of Adenocarcinoma of the Gastroesophageal Junction and Lower Esoph... | 51 |
Chapter 6 Esophageal CancerChemotherapy and Radiotherapy | 59 |
Chapter 7 The Role of Surgery in Cancer of the Stomach | 73 |
The Role of Adjuvant Radiotherapy in the Treatment of Gastric Adenocarcinoma | 85 |
Chapter 18 The Role of Combined Modality Therapy for Anal Cancer | 199 |
Chapter 19 The Role of Surgery for SquamousCell Cancer of the Anal Canal | 211 |
A Rationale for the Surgical Approach | 219 |
Chapter 21 The Role of Radiation Therapy for the Treatment of Pancreatic Adenocarcinoma | 231 |
Chapter 22 Does Adjuvant Chemotherapy Improve Outcomes in Pancreatic Adenocarcinoma? | 247 |
Chapter 23 Carcinoma of the Gallbladder and Bile Ducts | 259 |
Chemotherapy and Radiotherapy | 289 |
Chapter 25 Surgical Management of Hepatocellular Carcinoma | 299 |
Chapter 9 The Role of Chemotherapy and Chemoradiation as Adjuvant Treatment for Resected Gastric Adenocarcinoma | 97 |
Chapter 10 Small Bowel Adenocarcinoma | 107 |
A Critical Appraisal of EvidenceBased Data | 113 |
Chapter 12 Adjuvant Therapy for Colorectal Cancer | 125 |
Chapter 13 Chemotherapy for Metastatic Colorectal Cancer | 135 |
Chapter 14 The Role of Radiotherapy in the Management of Rectal Carcinoma | 149 |
Chapter 15 Metastatic Liver TumorsSurgical | 157 |
Chapter 16 The Role of Ablative Therapy for the Treatment of Metastatic Tumors of the Liver | 173 |
Chapter 17 The Role of Hepatic Arterial Infusion Chemotherapy in the Management of Patients with Hepatic Metastases from Colorectal Cancer | 181 |
Chaptre 26 Chemotherapy and Radiotherapy for the Treatment of Hepatocellular Carcinoma | 309 |
Chapter 27 Carcinoid Tumors | 317 |
Surgery | 337 |
Chapter 29 Chemotherapy and Other Nonsurgical Approaches for Gastrointestinal Lymphomas | 351 |
Chapter 30 Palliative Surgery in Advanced Gastrointestinal Malignancies | 365 |
| 375 | |
Back cover | 387 |
Inne wydania - Wyświetl wszystko
Kluczowe wyrazy i wyrażenia
addition adenocarcinoma adjuvant anal analysis Ann Surg approach associated Barrett’s benefit biliary biliary tract carcinoid carcinoma cell chemoradiation chemotherapy Clin Oncol clinical colon colorectal cancer combination compared complete complications curative demonstrated difference disease dose duct early effective endoscopic esophageal et al evaluation evidence factors five five-year fluorouracil followed gallbladder cancer gastric cancer gastrointestinal gemcitabine given hepatic imatinib improved increased infusion involvement lesions liver locally long-term lymph nodes lymphoma major malignant margins median survival metastases months morbidity mortality neoadjuvant obstruction Oncology operative outcome overall pancreatic cancer patients performed phase postoperative potentially preoperative present primary prognostic prospective radiation radiation therapy radiotherapy randomized received recent rectal recurrence remains reported resection response risk role selection showed significant stage Surg surgery surgical survival rate systemic therapy toxicity treated treatment trial tumors unresectable versus